DermTopic: Atopic Dermatitis

Filter Your Results

 

News

 

@PRACTICAL_DERM

img class="left" src="http://practicaldermatology.com/images/articles/2018-

Anti-IL22 Therapy May Represent New Treatment Option for Sev…

New research suggests that IL-22/Th22 targeting may offer a novel treatment alternative for patients with severe atopic …

Research Elucidates LIGHT’s Role in AD

LIGHT, a member of the tumor necrosis factor (TNF) super family, directly controls the hyperproliferation of keratinocyt…

GlobalData: Promising Future Forecasted for Dupixent

Regeneron Pharmaceuticals and Sanofi Genzyme’s Dupixent is currently the most successful biologic treatment for mo…

FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Design…

The FDA granted Breakthrough Therapy Designation for AbbVie's investigational, once-daily oral JAK1-selective inhibi…

New AD Yardstick Highlights Treatment Advances

Treatment for atopic dermatitis (AD) has changed a lot in the last few years, according to a new yardstick published in …

Therapeutics Update: Notable Approvals in 2017

One of the most widely anticipated approvals in 2017 was for Dupixent (dupilumab, Regeneron Pharmaceuticals, Inc.) injec…

Parent-supplied Photos May Allow Pediatric Derms to Make Vir…

Parent-supplied photos taken via smartphone cameras can allow pediatric dermatologists to make a diagnosis without …

 
 

Contact Info

For advertising rates and opportunities:
Rick Ehrlich
Group Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.